Journals have currently been the best and reliable source of information of the time. They always contain educative information that has been deeply researched and reviewed a factor that has led to their popularity. Among all the other journals being published and in the market today, Oncotarget tops them.
Unlike them all, Oncotarget publishes its articles twice in a week. Key topics that the journal covers include biomedical and information about oncology. The publication of the journal was started back in 2010 and is usually maintained by impact journals. Part of the people who have contributed a lot to its success is Mikhail Blagosklonny and Andrei V. Gudkov who have been editors in chief to date. Learn more about Oncotarget at Research Gate.
Among the many journals published by Oncotarget, most of its focus is centered on the pathological basis of all types of cancers. On this topic the major issues it addresses include the potential targets for therapy and the most effective treatment protocols that can be employed to improve the livelihood of the cancer patients.
Other key issues that the journal addresses include a focus on the impact better management programs for cancer patients. This has all been on a bid to come up with better ways to develop new therapeutic agents and treatment procedures that can be used to improve the quality of life of patients.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/
The publishers of the journal insist that it is only through adherence and satisfaction of the patients that the quality of their life can be achieved. To achieve this, the journal focuses on exploring evidence on both new and existing therapies that can help improve outcomes.
In the past ranking by Medline, Oncotarget has ranked the first position out of all other documents that were published between 2015 and 2016. They termed the journal as one of the most outstanding particularly on the field of oncology and cancer research.
They also recognize it as being significant not only to those working on cancer research but also on other fields of medicine. Other experts working in the field of oncology have also recognized the efforts of the journal. They have also gone ahead to proclaim their support to the Oncotarget research team. With this, the journal is expected to becoming even better in the future days. Follow Oncotarget on Linkedin.